Portland Business Journal — March 25, 2011 — The move to a new field came naturally to Chris Marsh.
Marsh, CEO of Portland-based Pulse Health LLC, is building on his tenure at Unicru Inc., where he grew annual sales tenfold to more than $60 million.
He anticipates similar results at Pulse Health, which markets a device called Revelar that helps medical professionals identify and minimize cell damage.
In the first quarter of 2011 alone, the company has already quadrupled its revenue from last year to $8 million. Marsh expects the company to turn its first profit next year.
About Pulse Health
Pulse Health was established in 2006 to deliver breakthrough breath technologies that can better identify health risks through the superior measurement of key biomarkers. Pulse Health has a science advisory board of nine physicians and scientists from around the world, representing the leaders in exhaled breath diagnostics, pulmonary disease, immunology, nutrition and biopharmaceuticals. Pulse Health’s Revelar™ is the first non-invasive device that measures aldehydes, known indicators of free radical damage. Revelar helps healthcare professionals test for damage caused by aldehydes and provides people insight to better impact their health and wellness. Revelar is available to healthcare professionals through www.myrevelar.com and also at www.facebook.com/pulsehealth and www.twitter.com/myrevelar
